Anne O’Dea
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Lymphatic System and Diseases
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 24
- Cancer Treatment and Pharmacology 9
- Cancer Immunotherapy and Biomarkers 6
- Cancer Cells and Metastasis 4
- HER2/EGFR in Cancer Research 4
-
- Breast Cancer Treatment Studies 11
- Cancer Genomics and Diagnostics 10
- Co-authors
- Qamar J. Khan (32 shared papers)Priyanka Sharma (32 shared papers)Bruce F. Kimler (17 shared papers)Carol J. Fabian (7 shared papers)Jennifer R. Klemp (7 shared papers)Pavan S. Reddy (2 shared papers)Lauren Nye (21 shared papers)Jamie L. Wagner (9 shared papers)
- Journals
- Journal of Clinical Oncology (20 papers)Cancer Research (7 papers)Nature Cancer (1 paper)Clinical Cancer Research (1 paper)Oncology nursing forum (1 paper)
- Partner nations
- United StatesBelgiumAustralia
In The Last Decade
Anne O’Dea
41 papers receiving 751 citations
Anne O’Dea's Hit Papers
Peers
Comparison fields: 5 of 77
- Oncology 363
- Cancer Research 192
- Pathology and Forensic Medicine 111
- Pulmonary and Respiratory Medicine 194
- Genetics 86
Countries citing papers authored by Anne O’Dea
This map shows the geographic impact of Anne O’Dea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne O’Dea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne O’Dea more than expected).
Fields of papers citing papers by Anne O’Dea
This network shows the impact of papers produced by Anne O’Dea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne O’Dea. The network helps show where Anne O’Dea may publish in the future.
Co-authors
The 25 scholars most cited alongside Anne O’Dea, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 154 | |
| 2 | Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer Hit paper breakdown → | 2023 | 92 |
| 3 | 2010 | 68 | |
| 4 | 2018 | 62 | |
| 5 | 2022 | 54 | |
| 6 | 2020 | 49 | |
| 7 | 2021 | 45 | |
| 8 | 2022 | 38 | |
| 9 | 2007 | 33 | |
| 10 | 2023 | 23 | |
| 11 | 2018 | 22 | |
| 12 | 2005 | 19 | |
| 13 | Clinicopathological characteristics of triple-negative invasive mammary carcinomas in African-American versus Caucasian women. | 2010 | 16 |
| 14 | 2021 | 16 | |
| 15 | 2019 | 8 | |
| 16 | 2023 | 7 | |
| 17 | 2018 | 7 | |
| 18 | 2023 | 4 | |
| 19 | 2023 | 4 | |
| 20 | 2017 | 4 |
About Anne O’Dea
Anne O’Dea is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Genetics, having authored 46 papers that have together received 767 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (11 papers), Breast Cancer Treatment Studies (11 papers), Cancer Genomics and Diagnostics (10 papers), Cancer Treatment and Pharmacology (9 papers), Cancer Immunotherapy and Biomarkers (6 papers), BRCA gene mutations in cancer (5 papers), Cancer Cells and Metastasis (4 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Oncology (363 citations), Cancer Research (192 citations), Pathology and Forensic Medicine (111 citations), Pulmonary and Respiratory Medicine (194 citations) and Genetics (86 citations). Anne O’Dea has collaborated with scholars based in United States, Belgium and Australia. Frequent co-authors include Qamar J. Khan, Priyanka Sharma, Bruce F. Kimler, Carol J. Fabian, Jennifer R. Klemp, Pavan S. Reddy, Lauren Nye, Jamie L. Wagner, Andrew K. Godwin and Kelsey E. Larson. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Nature Cancer, Clinical Cancer Research and Oncology nursing forum.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.